Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America

ABSTRACT: The conventional means of diagnosis of histoplasmosis presents difficulties because of the delay to the time that the diagnosis is made, indicating the need for the implementation of molecular assays. We evaluated 146 clinical samples from 135 patients suspected of having histoplasmosis us...

Full description

Autores:
Muñoz Cadavid, Cesar Orlando
González Marín, Ángel Augusto
Tobón Orozco, Ángela María
Restrepo Moreno, Ángela
Muskus López, Carlos Enrique
Cano Restrepo, Luz Elena
Correa Ochoa, Margarita María
Arango Bustamante, Karen
Tipo de recurso:
Article of investigation
Fecha de publicación:
2010
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/24082
Acceso en línea:
http://hdl.handle.net/10495/24082
Palabra clave:
Histoplasma
Histoplasmosis
Diagnóstico
Diagnosis
Reacción en Cadena de la Polimerasa
Polymerase Chain Reaction
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
id UDEA2_b8922ab1507c93cb1fa006d2e9fb9260
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/24082
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
title Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
spellingShingle Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
Histoplasma
Histoplasmosis
Diagnóstico
Diagnosis
Reacción en Cadena de la Polimerasa
Polymerase Chain Reaction
title_short Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
title_full Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
title_fullStr Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
title_full_unstemmed Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
title_sort Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America
dc.creator.fl_str_mv Muñoz Cadavid, Cesar Orlando
González Marín, Ángel Augusto
Tobón Orozco, Ángela María
Restrepo Moreno, Ángela
Muskus López, Carlos Enrique
Cano Restrepo, Luz Elena
Correa Ochoa, Margarita María
Arango Bustamante, Karen
dc.contributor.author.none.fl_str_mv Muñoz Cadavid, Cesar Orlando
González Marín, Ángel Augusto
Tobón Orozco, Ángela María
Restrepo Moreno, Ángela
Muskus López, Carlos Enrique
Cano Restrepo, Luz Elena
Correa Ochoa, Margarita María
Arango Bustamante, Karen
dc.subject.decs.none.fl_str_mv Histoplasma
Histoplasmosis
Diagnóstico
Diagnosis
Reacción en Cadena de la Polimerasa
Polymerase Chain Reaction
topic Histoplasma
Histoplasmosis
Diagnóstico
Diagnosis
Reacción en Cadena de la Polimerasa
Polymerase Chain Reaction
description ABSTRACT: The conventional means of diagnosis of histoplasmosis presents difficulties because of the delay to the time that the diagnosis is made, indicating the need for the implementation of molecular assays. We evaluated 146 clinical samples from 135 patients suspected of having histoplasmosis using a previously reported nested PCR assay for the Histoplasma capsulatum-specific 100-kDa protein (the Hc100 PCR). In order to determine the specificity of this molecular test, we also used samples from healthy individuals (n _ 20), patients suspected of having respiratory disease with negative fungal cultures (n _ 29), and patients with other proven infections (n _ 60). Additionally, a sizable collection of DNA from cultures of H. capsulatum and other medically relevant pathogens was studied. A panfungal PCR assay that amplified the internal transcribed spacer 2 region was also used to identify all fungal DNAs. All PCR-amplified products were sequenced. Of the 146 clinical samples, 67 (45.9%) were positive by culture and PCR, while 9 samples negative by culture were positive by PCR. All the sequences corresponding to the 76 amplified products presented >98% identity with H. capsulatum. The Hc100 PCR exhibited a sensitivity of 100% and specificities of 92.4% and 95.2% when the results were compared to those for the negative controls and samples from other proven clinical entities, respectively; the positive predictive value was 83% and the negative predictive value was 100%; the positive and negative likelihood rates were 25 and 0, respectively. These results suggest that the Hc100 nested PCR assay for the detection of H. capsulatum DNA is a useful test in areas where mycosis caused by this organism is endemic.
publishDate 2010
dc.date.issued.none.fl_str_mv 2010
dc.date.accessioned.none.fl_str_mv 2021-11-13T23:32:41Z
dc.date.available.none.fl_str_mv 2021-11-13T23:32:41Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 1556-6811
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/24082
dc.identifier.doi.none.fl_str_mv 10.1128/CVI.00332-09
dc.identifier.eissn.none.fl_str_mv 1556-679X
identifier_str_mv 1556-6811
10.1128/CVI.00332-09
1556-679X
url http://hdl.handle.net/10495/24082
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Clin. Vaccine Immunol.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.format.extent.spa.fl_str_mv 6
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv American Society for Microbiology
dc.publisher.group.spa.fl_str_mv Micología Médica y Experimental
Microbiología Molecular
Programa de Estudio y Control de Enfermedades Tropicales (PECET)
dc.publisher.place.spa.fl_str_mv Washington, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/24082/1/Mu%c3%b1ozCesar_2010_ApplicationMolecularHuman.pdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/24082/2/license_rdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/24082/3/license.txt
bitstream.checksum.fl_str_mv f8f57c935e0bdeb336a866dae97276dd
1646d1f6b96dbbbc38035efc9239ac9c
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1805390129031806976
spelling Muñoz Cadavid, Cesar OrlandoGonzález Marín, Ángel AugustoTobón Orozco, Ángela MaríaRestrepo Moreno, ÁngelaMuskus López, Carlos EnriqueCano Restrepo, Luz ElenaCorrea Ochoa, Margarita MaríaArango Bustamante, Karen2021-11-13T23:32:41Z2021-11-13T23:32:41Z20101556-6811http://hdl.handle.net/10495/2408210.1128/CVI.00332-091556-679XABSTRACT: The conventional means of diagnosis of histoplasmosis presents difficulties because of the delay to the time that the diagnosis is made, indicating the need for the implementation of molecular assays. We evaluated 146 clinical samples from 135 patients suspected of having histoplasmosis using a previously reported nested PCR assay for the Histoplasma capsulatum-specific 100-kDa protein (the Hc100 PCR). In order to determine the specificity of this molecular test, we also used samples from healthy individuals (n _ 20), patients suspected of having respiratory disease with negative fungal cultures (n _ 29), and patients with other proven infections (n _ 60). Additionally, a sizable collection of DNA from cultures of H. capsulatum and other medically relevant pathogens was studied. A panfungal PCR assay that amplified the internal transcribed spacer 2 region was also used to identify all fungal DNAs. All PCR-amplified products were sequenced. Of the 146 clinical samples, 67 (45.9%) were positive by culture and PCR, while 9 samples negative by culture were positive by PCR. All the sequences corresponding to the 76 amplified products presented >98% identity with H. capsulatum. The Hc100 PCR exhibited a sensitivity of 100% and specificities of 92.4% and 95.2% when the results were compared to those for the negative controls and samples from other proven clinical entities, respectively; the positive predictive value was 83% and the negative predictive value was 100%; the positive and negative likelihood rates were 25 and 0, respectively. These results suggest that the Hc100 nested PCR assay for the detection of H. capsulatum DNA is a useful test in areas where mycosis caused by this organism is endemic.COL0013709COL0013746COL00150996application/pdfengAmerican Society for MicrobiologyMicología Médica y ExperimentalMicrobiología MolecularPrograma de Estudio y Control de Enfermedades Tropicales (PECET)Washington, Estados Unidosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by/4.0/Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South AmericaHistoplasmaHistoplasmosisDiagnósticoDiagnosisReacción en Cadena de la PolimerasaPolymerase Chain ReactionClin. Vaccine Immunol.Clinical and Vaccine Immunology6267171ORIGINALMuñozCesar_2010_ApplicationMolecularHuman.pdfMuñozCesar_2010_ApplicationMolecularHuman.pdfArtículo de investigaciónapplication/pdf72721http://bibliotecadigital.udea.edu.co/bitstream/10495/24082/1/Mu%c3%b1ozCesar_2010_ApplicationMolecularHuman.pdff8f57c935e0bdeb336a866dae97276ddMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927http://bibliotecadigital.udea.edu.co/bitstream/10495/24082/2/license_rdf1646d1f6b96dbbbc38035efc9239ac9cMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/24082/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/24082oai:bibliotecadigital.udea.edu.co:10495/240822022-04-22 10:20:47.813Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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